PT81382B - Processo para a preparacao de espiro-heteroazolonas - Google Patents

Processo para a preparacao de espiro-heteroazolonas

Info

Publication number
PT81382B
PT81382B PT81382A PT8138285A PT81382B PT 81382 B PT81382 B PT 81382B PT 81382 A PT81382 A PT 81382A PT 8138285 A PT8138285 A PT 8138285A PT 81382 B PT81382 B PT 81382B
Authority
PT
Portugal
Prior art keywords
nitrogen
hydrogen
methine
alkyl
carbon atoms
Prior art date
Application number
PT81382A
Other languages
English (en)
Other versions
PT81382A (en
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT81382A publication Critical patent/PT81382A/pt
Publication of PT81382B publication Critical patent/PT81382B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
PT81382A 1984-10-30 1985-10-28 Processo para a preparacao de espiro-heteroazolonas PT81382B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001767 WO1986002647A1 (en) 1984-10-30 1984-10-30 Spiro-heteroazolones for treatment of diabetes complications

Publications (2)

Publication Number Publication Date
PT81382A PT81382A (en) 1985-11-01
PT81382B true PT81382B (pt) 1987-11-30

Family

ID=22182314

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81382A PT81382B (pt) 1984-10-30 1985-10-28 Processo para a preparacao de espiro-heteroazolonas

Country Status (17)

Country Link
EP (1) EP0180421B1 (pt)
JP (1) JPS61109789A (pt)
KR (1) KR870000625B1 (pt)
AT (1) ATE66228T1 (pt)
AU (1) AU553839B2 (pt)
DE (1) DE3583791D1 (pt)
DK (1) DK166150C (pt)
ES (1) ES8704168A1 (pt)
FI (1) FI83322C (pt)
GR (1) GR852606B (pt)
HU (1) HU198051B (pt)
IE (1) IE58287B1 (pt)
IL (1) IL76855A0 (pt)
PH (1) PH23491A (pt)
PL (2) PL152323B1 (pt)
PT (1) PT81382B (pt)
WO (1) WO1986002647A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4147795A (en) * 1977-02-11 1979-04-03 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives

Also Published As

Publication number Publication date
KR860003262A (ko) 1986-05-21
AU553839B2 (en) 1986-07-31
HU198051B (en) 1989-07-28
PL152323B1 (en) 1990-12-31
FI862634A (fi) 1986-06-19
PL255978A1 (en) 1987-07-13
DE3583791D1 (de) 1991-09-19
JPS61109789A (ja) 1986-05-28
EP0180421B1 (en) 1991-08-14
PL152316B1 (en) 1990-12-31
IL76855A0 (en) 1986-02-28
DK166150B (da) 1993-03-15
DK166150C (da) 1993-08-09
IE58287B1 (en) 1993-08-25
PH23491A (en) 1989-08-16
FI862634A0 (fi) 1986-06-19
IE852695L (en) 1986-04-30
ES548271A0 (es) 1987-03-16
ES8704168A1 (es) 1987-03-16
HUT40659A (en) 1987-01-28
PT81382A (en) 1985-11-01
DK495285D0 (da) 1985-10-29
ATE66228T1 (de) 1991-08-15
GR852606B (pt) 1986-03-04
WO1986002647A1 (en) 1986-05-09
KR870000625B1 (ko) 1987-03-26
EP0180421A1 (en) 1986-05-07
FI83322B (fi) 1991-03-15
DK495285A (da) 1986-05-01
AU4916485A (en) 1986-05-08
FI83322C (fi) 1991-06-25

Similar Documents

Publication Publication Date Title
AU2872889A (en) Quinoline, quinazoline, and cinnoline fungicides
PT91602A (pt) Processo para a preparacao de compostos espiro com accao antibacteriana e de composicoes farmaceuticas que os contem
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
BR8901097A (pt) Processo para a preparacao de uma composicao biocida
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
BR8805502A (pt) Formulacao fungicida,metodo fungicida e processo para preparar um composto
PT81382B (pt) Processo para a preparacao de espiro-heteroazolonas
PT89935A (pt) Processo para a preparacao de novos compostos cefem
ES8606295A1 (es) Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas.
MX9205408A (es) Metodo para tratar hipertension.
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
BR9105715A (pt) Composicao fungicida,composto,e processos para a preparacao de um composto e para o controle de fungos fitopatogenicos
DE3362523D1 (en) Optically active imidazolylpropanol compounds, and their production and use
GR3015002T3 (en) 1,4-Dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents.
ES8505667A1 (es) Procedimiento para preparar 4-(sustituida alquil)-n-(1,3-ditiolan-2-ilideno)anilina
HU903953D0 (en) Process for producing imidazole derivatives
BR9005673A (pt) Composicao microbiocida e processo para preparar um composto de benzoxazolonas
BR8804669A (pt) Processo para a preparacao de um composto

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19951130